Table 1 Patients’ characteristics at surgery in the two groups
CRS only n = 30 | CRS + HIPEC n = 30 | Paired differences | p | |
|---|---|---|---|---|
Age (years) | 63.9 (60.5;67.2) | 60.9 (58.9;62.9) | − 2.5 (− 4.5;− 0.5) | 0.004‡ |
Tumor histology | ||||
Endometrioid adenocarcinoma | 27 (90.0%) | 27 (90.0%) | – | 1‡ |
Carcinosarcoma | 1 (3.3%) | 1 (3.3%) | ||
Other | 2 (6.7%) | 2 (6.7%) | ||
Surgery | < 0.001 | |||
Primary | 25 (83.3%) | 1 (3.3%) | − 80.0% (− 97.0%;− 63.0%) | |
Recurrence | 5 (16.7%) | 29 (96.7%) | – | |
Months since diagnosis | 2.1 (5.4;19.5)* | 6.8 (5.1;9.2)* | 3.9 (− 0.1;8.5)* | 0.001 |
Systemic chemotherapy◊ | ||||
Neoadjuvant | 3 (10.0%) | 11 (44.7%) | 30.7% (11.1%;50.4%) | 0.011 |
Adjuvant | 27 (90.0%) | 16 (59.4%) | – | |
PCI | 10.0 (5.6;14.4) | 9.9 (7.5;12.2] | − 0.1 (− 4.3;4.1) | 0.702 |
CC score∆ | ||||
CC-0 | 21 (72.4%) | 23 (79.3%) | 6.9% (− 6.1%;29.9%) | 0.763 |
CC-1 or CC-2 | 8 (25.6%) | 6 (20.7%) | – | |
Surgery duration (hours) | 4.0 (3.3;4.6) | 6.1 (5.3;6.9) | 2.1 (1.0;3.1) | 0.006 |